Delivery Order SPE2DR25D3013-SPE2DR26F6V9V
- Not listed
- The Defense Logistics Agency awarded a $1,205.46 delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Zepbound 2.5 mg/0.5 ml pen injections. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order carries no set-aside designation and is scheduled for completion by December 24, 2025,...
- The Defense Logistics Agency awarded a $7,509.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen injections on August 19, 2025, with ultimate completion scheduled for August 20, 2025. This competitive award, placed under no set-aside designation, represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement...
- The Defense Logistics Agency awarded a $1,107.42 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 ml pen injections on December 9, 2025, with completion scheduled for December 10, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be performed at...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,077.99 by the Defense Logistics Agency (DLA) on December 17, 2025, for the supply of Zepbound 15 mg/0.5 mL pen injections. This competitively awarded, firm fixed-price contract is classified as a child delivery order and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 18, 2025. The award represents a continuation of AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a $8,050.33 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injections, with a completion date of December 10, 2025. This is a firm fixed-price, non-set-aside contract utilizing AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The contract is being performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at approximately $35.9K to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on December 4, 2025, with completion scheduled for December 5, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded a $12,054.66 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 mL pen injections on December 29, 2025, with completion scheduled for December 30, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $6,644.52 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on December 3, 2025, with completion targeted for December 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,143.87 firm fixed-price delivery order on July 22, 2025, for Zepbound 15 mg/0.5 ml pen injections. This is a competitively awarded, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and an ultimate completion date of July 23, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on December 22, 2025, by the Defense Logistics Agency (DLA) for the supply of Zepbound 12.5 mg/0.5 mL pens with a ceiling value of $32,773.68. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 23, 2025, and was competitively awarded with no set-aside designation. This delivery order is issued under...
- SPE2DR25D3013Indefinite Delivery Contract
- SPE2DR25D3013-SPE2DR26F6V9VDelivery Order
The Defense Logistics Agency awarded a $15,621.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections with a completion date of January 2, 2026. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is listed as Conshohocken, Pennsylvania, the company's corporate headquarters. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies a comprehensive portfolio of pharmaceuticals and medical supplies across multiple therapeutic domains to military and veteran healthcare systems. This delivery order for Zepbound, a GLP-1 receptor agonist used in diabetes and weight management treatment, demonstrates the company's capability to fulfill specialized pharmaceutical requirements through the DLA's global pharmaceutical support vehicle. The contract reflects AmerisourceBergen's position as a critical vendor in the Defense Health Agency's medical supply chain, supporting military healthcare operations through competitively awarded, firm fixed-price transactions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.6k | 12/30/25 |